{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:47:02Z","timestamp":1793951222919,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1038\/s41409-024-02313-3","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T13:02:03Z","timestamp":1716642123000},"page":"1224-1231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era"],"prefix":"10.1038","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6728-3346","authenticated-orcid":false,"given":"Toshiki","family":"Terao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-8266","authenticated-orcid":false,"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-7950","authenticated-orcid":false,"given":"Shigeo","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunto","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7436-972X","authenticated-orcid":false,"given":"Takashi","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8661-3179","authenticated-orcid":false,"given":"Noriko","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohigashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4523-2994","authenticated-orcid":false,"given":"Shin-ichiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4866-9307","authenticated-orcid":false,"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3631-244X","authenticated-orcid":false,"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Ishimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-5878","authenticated-orcid":false,"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-7857","authenticated-orcid":false,"given":"Kimikazu","family":"Yakushijin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5812-9315","authenticated-orcid":false,"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"2313_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cid\/cit358","volume":"57","author":"M Ogata","year":"2013","unstructured":"Ogata M, Satou T, Kadota J, Saito N, Yoshida T, Okumura H, et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis. 2013;57:671\u201381.","journal-title":"Clin Infect Dis"},{"key":"2313_CR2","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.bbmt.2012.04.016","volume":"18","author":"JA Hill","year":"2012","unstructured":"Hill JA, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J, et al. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transpl. 2012;18:1638\u201348.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2313_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/bmt.2012.180","volume":"48","author":"ME Scheurer","year":"2013","unstructured":"Scheurer ME, Pritchett JC, Amirian ES, Zemke NR, Lusso P, Ljungman P. HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transpl. 2013;48:574\u201380.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/498531","volume":"193","author":"M Ogata","year":"2006","unstructured":"Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K, et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis. 2006;193:68\u201379.","journal-title":"J Infect Dis"},{"key":"2313_CR5","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/bmt.2017.175","volume":"52","author":"M Ogata","year":"2017","unstructured":"Ogata M, Oshima K, Ikebe T, Takano K, Kanamori H, Kondo T, et al. Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2017;52:1563\u201370.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR6","doi-asserted-by":"publisher","first-page":"e12682","DOI":"10.1111\/tid.12682","volume":"19","author":"N Miyashita","year":"2017","unstructured":"Miyashita N, Endo T, Onozawa M, Hashimoto D, Kondo T, Fujimoto K, et al. Risk factors of human herpesvirus 6 encephalitis\/myelitis after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2017;19:e12682.","journal-title":"Transpl Infect Dis"},{"key":"2313_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jtct.2021.05.001","volume":"27","author":"M Hakki","year":"2021","unstructured":"Hakki M, Aitken SL, Danziger-Isakov L, Michaels MG, Carpenter PA, Chemaly RF, et al. American Society for transplantation and cellular therapy series: #3\u2014prevention of Cytomegalovirus infection and disease after hematopoietic cell transplantation. Transplant Cell Ther. 2021;27:707\u201319.","journal-title":"Transplant Cell Ther"},{"key":"2313_CR8","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3324\/haematol.2019.223073","volume":"104","author":"KN Ward","year":"2019","unstructured":"Ward KN, Hill JA, Hubacek P, de la Camara R, Crocchiolo R, Einsele H, et al. Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation. Haematologica. 2019;104:2155\u201363.","journal-title":"Haematologica"},{"key":"2313_CR9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.bbmt.2018.02.008","volume":"24","author":"M Ogata","year":"2018","unstructured":"Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, et al. Effects of prophylactic foscarnet on human Herpesvirus-6 reactivation and encephalitis in cord blood transplant recipients: a prospective multicenter trial with an historical control group. Biol Blood Marrow Transpl. 2018;24:1264\u201373.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2313_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40265-017-0860-8","volume":"78","author":"ES Kim","year":"2018","unstructured":"Kim ES. Letermovir: first global approval. Drugs. 2018;78:147\u201352.","journal-title":"Drugs"},{"key":"2313_CR11","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","volume":"377","author":"FM Marty","year":"2017","unstructured":"Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, et al. Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N. Engl J Med. 2017;377:2433\u201344.","journal-title":"N. Engl J Med"},{"key":"2313_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41409-020-01082-z","volume":"56","author":"Y Mori","year":"2021","unstructured":"Mori Y, Jinnouchi F, Takenaka K, Aoki T, Kuriyama T, Kadowaki M, et al. Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data. Bone Marrow Transpl. 2021;56:853\u201362.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR13","doi-asserted-by":"publisher","first-page":"ofac687","DOI":"10.1093\/ofid\/ofac687","volume":"10","author":"A Vyas","year":"2023","unstructured":"Vyas A, Raval AD, Kamat S, LaPlante K, Tang Y, Chemaly RF. Real-world outcomes associated with letermovir use for cytomegalovirus primary prophylaxis in allogeneic hematopoietic cell transplant recipients: a systematic review and meta-analysis of observational studies. Open Forum Infect Dis. 2023;10:ofac687.","journal-title":"Open Forum Infect Dis"},{"key":"2313_CR14","doi-asserted-by":"crossref","unstructured":"Kampouri E, Krantz EM, Zamora D, Kimball LE, Kiem E, Lovas EA, et al. 2109 HHV-6 and EBV reactivation after allogeneic hematopoietic cell transplantation in the era of letermovir for CMV prophylaxis: a retrospective cohort study. Open Forum Infect. Dis. 2022;9:ofac492.1730.","DOI":"10.1093\/ofid\/ofac492.1730"},{"key":"2313_CR15","doi-asserted-by":"crossref","unstructured":"Srinivasan K, Spallone A, Khawaja F, Sassine J, Aramburo OM, Febres-Aldana AJ, et al. 2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir. Open Forum Infect. Dis. 2022;9:ofac492.1743.","DOI":"10.1093\/ofid\/ofac492.1743"},{"key":"2313_CR16","doi-asserted-by":"crossref","unstructured":"Kampouri E, Zamora D, Kiem ES, Liu W, Ibrahimi S, Blazevic RL, et al. Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis. Clin Microbiol Infect. 2023;29:1450.e1\u20131450.e7.","DOI":"10.1016\/j.cmi.2023.07.026"},{"key":"2313_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1532\/IJH97.06239","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86:269\u201374.","journal-title":"Int J Hematol"},{"key":"2313_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol. 2016;103:3\u201310.","journal-title":"Int J Hematol"},{"key":"2313_CR19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2017-03-775759","volume":"130","author":"JA Hill","year":"2017","unstructured":"Hill JA, Magaret AS, Hall-Sedlak R, Mikhaylova A, Huang ML, Sandmaier BM, et al. Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6. Blood. 2017;130:1062\u20139.","journal-title":"Blood"},{"key":"2313_CR20","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/jmv.25244","volume":"90","author":"H Miura","year":"2018","unstructured":"Miura H, Kawamura Y, Hattori F, Kozawa K, Ihira M, Ohye T, et al. Chromosomally integrated human herpesvirus 6 in the Japanese population. J Med Virol. 2018;90:1636\u201342.","journal-title":"J Med Virol"},{"key":"2313_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transpl. 2009;15:367\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2313_CR22","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl. 1995;15:825\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl. 2015;21:389\u2013401.e381.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2313_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR25","doi-asserted-by":"publisher","first-page":"84.e81","DOI":"10.1016\/j.bbmt.2020.10.008","volume":"27","author":"N El Jurdi","year":"2021","unstructured":"El Jurdi N, Rogosheske J, DeFor T, Bejanyan N, Arora M, Bachanova V, et al. Prophylactic Foscarnet for Human Herpesvirus 6: effect on hematopoietic engraftment after reduced-intensity conditioning umbilical cord blood transplantation. Transpl Cell Ther. 2021;27:84.e81\u201384.e85.","journal-title":"Transpl Cell Ther"},{"key":"2313_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.bmt.1705907","volume":"41","author":"M Ogata","year":"2008","unstructured":"Ogata M, Satou T, Kawano R, Goto K, Ikewaki J, Kohno K, et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant. 2008;41:279\u201385. 2008\/02\/01","journal-title":"Bone Marrow Transplant"},{"key":"2313_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/bmt.2010.201","volume":"46","author":"K Ishiyama","year":"2011","unstructured":"Ishiyama K, Katagiri T, Hoshino T, Yoshida T, Yamaguchi M, Nakao S. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT. Bone Marrow Transpl. 2011;46:863\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/bmt.2012.121","volume":"48","author":"M Ogata","year":"2013","unstructured":"Ogata M, Satou T, Inoue Y, Takano K, Ikebe T, Ando T, et al. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis. Bone Marrow Transpl. 2013;48:257\u201364.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12185-019-02672-4","volume":"110","author":"H Yamamoto","year":"2019","unstructured":"Yamamoto H. Single cord blood transplantation in Japan; expanding the possibilities of CBT. Int J Hematol. 2019;110:39\u201349.","journal-title":"Int J Hematol"},{"key":"2313_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1182\/hematology.2022000327","volume":"2022","author":"A Nagler","year":"2022","unstructured":"Nagler A, Mohty M. In 2022, which is preferred: haploidentical or cord transplant? Hematol Am Soc Hematol Educ Program. 2022;2022:64\u201373.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"2313_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/bmt.2016.18","volume":"51","author":"D Niederwieser","year":"2016","unstructured":"Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transpl. 2016;51:778\u201385.","journal-title":"Bone Marrow Transpl"},{"key":"2313_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12185-017-2347-5","volume":"107","author":"T Ueki","year":"2018","unstructured":"Ueki T, Hoshi K, Hiroshima Y, Sumi M, Ichikawa N, Ogata M, et al. Analysis of five cases of human herpesvirus-6 myelitis among 121 cord blood transplantations. Int J Hematol. 2018;107:363\u201372.","journal-title":"Int J Hematol"},{"key":"2313_CR33","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2169\/internalmedicine.51.6640","volume":"51","author":"M Nishimoto","year":"2012","unstructured":"Nishimoto M, Nakamae H, Hayashi Y, Koh H, Nakane T, Yoshida M, et al. Prolonged sinus tachycardia caused by human herpesvirus 6 (HHV6) encephalomyelitis after allogeneic bone marrow transplantation. Intern Med. 2012;51:1265\u20137.","journal-title":"Intern Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02313-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T13:08:00Z","timestamp":1725282480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02313-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2313"],"URL":"https:\/\/doi.org\/10.1038\/s41409-024-02313-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the authors used ChatGPT (), an AI language model developed by OpenAI, for English language proofreading and editing in order to improve the quality of the manuscript and to modify of statistical analysis code. After using ChatGPT, the authors reviewed and edited the content as needed to ensure accuracy and clarity and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted technologies in the writing process"}},{"value":"All procedures performed in the study were in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was designed by the Donor\/Source Working Group and the Transplant Complications Working Group of the JSTCT and was approved by the Transplant Registry Unified Management Program Data Management Committee of the JSTCT and the Institutional Review Board of Okayama University Hospital (2401-004), where the study was conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent for data reporting.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}